Novartis AG vs Vipshop Holdings Ltd - ADR — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Vipshop Holdings Ltd - ADR trades at $14.63 (market cap $7.01B). The key difference: Novartis AG is far larger — about 41.4× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.25%). Which is the better fit depends on your goals.
| NVS | VIPS | |
|---|---|---|
Market Cap | $290.25B | $7.01B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $20.68 |
52-Week Low | $113.50 | $12.92 |
Enterprise Value | $330.27B | $3.60B |
Dividend Yield | 3.17% | 4.25% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →